In murine models, AdipoR2 deficiency leads to hyperinsulinemia, reduced PPAR-α activation, and increased oxidative stress and hepatic inflammation [47], whereas its overexpression improves glucose homeostasis, insulin sensitivity, and reduces hepatic steatosis [48]. Here, PPARA is linked to fatty liver disease.